Technology

July 14, 2015.

The European Medicines Agency (EMA) has started a review of human papillomavirus (HPV) vaccines to further clarify aspects of their safety profile.HPVvaccines have been used in around 72 million people worldwide to prevent cervical cancer and other cancers and conditions caused by HPV. Cervical cancer is the fourth most common cause of cancer death in women worldwide.

July 10, 2015.

All indications are that the July 2016 deadline for transition from Europe's eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) to the new Identification of Medicinal Products (IDMP) is not achievable. Sophie Daniels reports.

July 9, 2015.

July 9, 2015.

July 9, 2015.

July 6, 2015.

July 7, 2015.

June 29, 2015.

29 June, 2015.

June 29, 2015.

As the industry continues to face declining R&D productivity, one efficient way of making the failure rate lower is to use data, writes Adam Towvim.

The Tufts Center for the Study of Drug Development (CSDD) released a new report highlighting innovative approaches across the R&D continuum that pharmaceutical companies are implementing to drive efficiency and lower cost.

June 26, 2015.

June 25, 2015.

June 24, 2015.

June 23, 2015.

June 22, 2015.

June 19, 2015.

June 18, 2015.

June 18, 2015.

June 17, 2015.

June 17, 2015.

June 16, 2015.

June 15, 2015.

June 9, 2015.

CPhI Pharma Insights’ Turkey Market Report reveals, the growth and strategic plans for the future of the pharmaceutical industry in Turkey.

June 8, 2015.

June 5, 2015.